Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma

Published:2022-04-12 Issue:5 Volume:8 Page:e1313
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:

Author:

Shaikh Anjiya,Goli Karthik,Rich Nicole E.,Benhammou Jihane N.,Khaderi Saira,Hernaez Ruben,Agopian Vatche G.,Vierling John M.,Kim Donghee,Ahmed Aijaz,Goss John A.,Rana Abbas,Kanwal Fasiha,Cholankeril George

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference17 articles.

1. MELD and PELD: application of survival models to liver allocation.;Wiesner;Liver Transpl,2001

2. United States liver allocation.;Heimbach;Curr Opin Organ Transplant,2020

3. Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States.;Yang;Clin Gastroenterol Hepatol,2017

4. Advances and future directions in the treatment of hepatocellular carcinoma.;Gosalia;Gastroenterol Hepatol (N Y),2017

5. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.;Piscaglia;Liver Transpl,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications;Hepatology Communications;2024-07

2. The Future Frontier of Liver Transplantation Exploring Young Donor Allocation Strategies for HCC Recipients;Transplantation Direct;2024-06-13

3. Indications and outcomes of liver transplantation for liver tumors in the United States;Surgery in Practice and Science;2024-06

4. Racial–ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy;Clinical Transplantation;2024-05-28

5. Development and Internal Validation of a Novel Pre-Transplant Biomarker Panel to Predict Post-Transplant Mortality in Liver Transplant Recipients;2024-04-01